Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
more 26 30 26 30 O
or 31 33 31 33 O
equal 34 39 34 39 O
to 40 42 40 42 O
750 43 46 43 46 B-lower_bound
/ 46 47 46 47 I-lower_bound
mL 47 49 47 49 I-lower_bound

Congenital 0 10 50 60 B-chronic_disease
long 11 15 61 65 I-chronic_disease
QT 16 18 66 68 I-chronic_disease
syndrome 19 27 69 77 I-chronic_disease

Creatinine 0 10 78 88 B-clinical_variable
less 11 15 89 93 O
or 16 18 94 96 O
equal 19 24 97 102 O
to 25 27 103 105 O
3 28 29 106 107 B-upper_bound
x 30 31 108 109 I-upper_bound
upper 32 37 110 115 I-upper_bound
limit 38 43 116 121 I-upper_bound
of 44 46 122 124 I-upper_bound
normal 47 53 125 131 I-upper_bound
( 54 55 132 133 I-upper_bound
ULN 55 58 133 136 I-upper_bound
) 58 59 136 137 I-upper_bound

Eastern 0 7 138 145 B-clinical_variable
Cooperative 8 19 146 157 I-clinical_variable
Oncology 20 28 158 166 I-clinical_variable
Group 29 34 167 172 I-clinical_variable
( 35 36 173 174 I-clinical_variable
ECOG 36 40 174 178 I-clinical_variable
) 40 41 178 179 I-clinical_variable
performance 42 53 180 191 I-clinical_variable
status 54 60 192 198 I-clinical_variable
should 61 67 199 205 O
be 68 70 206 208 O
less 71 75 209 213 O
or 76 78 214 216 O
equal 79 84 217 222 O
to 85 87 223 225 O
3 88 89 226 227 B-upper_bound

History 0 7 228 235 O
( 8 9 236 237 O
within 9 15 237 243 O
the 16 19 244 247 O
last 20 24 248 252 B-upper_bound
3 25 26 253 254 I-upper_bound
months 27 33 255 261 I-upper_bound
) 33 34 261 262 O
or 35 37 263 265 O
presence 38 46 266 274 O
of 47 49 275 277 O
stroke 50 56 278 284 B-chronic_disease
/ 56 57 284 285 O
cerebrovascular 57 72 285 300 B-chronic_disease
accident 73 81 301 309 I-chronic_disease

History 0 7 310 317 O
of 8 10 318 320 O
hypersensitivity 11 27 321 337 O
to 28 30 338 340 O
any 31 34 341 344 B-allergy_name
component 35 44 345 354 I-allergy_name
of 45 47 355 357 I-allergy_name
the 48 51 358 361 I-allergy_name
formulation 52 63 362 373 I-allergy_name

History 0 7 374 381 O
of 8 10 382 384 O
hypersensitivity 11 27 385 401 O
to 28 30 402 404 O
sirolimus 31 40 405 414 B-treatment
, 40 41 414 415 O
temsirolimus 42 54 416 428 B-treatment
, 54 55 428 429 O
everolimus 56 66 430 440 B-treatment

History 0 7 441 448 O
of 8 10 449 451 O
hypersensitivity 11 27 452 468 O
to 28 30 469 471 O
vandetanib 31 41 472 482 B-allergy_name
, 41 42 482 483 O
lactose 43 50 484 491 B-allergy_name
, 50 51 491 492 O
murine 52 58 493 499 B-allergy_name
products 59 67 500 508 I-allergy_name
, 67 68 508 509 O
or 69 71 510 512 O
any 72 75 513 516 O
component 76 85 517 526 B-allergy_name
of 86 88 527 529 I-allergy_name
the 89 92 530 533 I-allergy_name
formulation 93 104 534 545 I-allergy_name

Patients 0 8 546 554 O
must 9 13 555 559 O
be 14 16 560 562 O
at 17 19 563 565 O
least 20 25 566 571 O
3 26 27 572 573 B-lower_bound
weeks 28 33 574 579 I-lower_bound
beyond 34 40 580 586 O
their 41 46 587 592 O
previous 47 55 593 601 O
cytotoxic 56 65 602 611 B-treatment
chemotherapy 66 78 612 624 I-treatment
; 78 79 624 625 O
patient 80 87 626 633 O
must 88 92 634 638 O
be 93 95 639 641 O
at 96 98 642 644 O
least 99 104 645 650 O
5 105 106 651 652 B-lower_bound
half 107 111 653 657 O
- 111 112 657 658 O
lives 112 117 658 663 O
or 118 120 664 666 O
3 121 122 667 668 O
weeks 123 128 669 674 O
, 128 129 674 675 O
whichever 130 139 676 685 O
is 140 142 686 688 O
shorter 143 150 689 696 O
, 150 151 696 697 O
from 152 156 698 702 O
their 157 162 703 708 O
previous 163 171 709 717 O
targeted 172 180 718 726 O
or 181 183 727 729 O
biologic 184 192 730 738 B-treatment
therapy 193 200 739 746 I-treatment
; 200 201 746 747 O
in 202 204 748 750 O
addition 205 213 751 759 O
, 213 214 759 760 O
patients 215 223 761 769 O
must 224 228 770 774 O
be 229 231 775 777 O
at 232 234 778 780 O
least 235 240 781 786 O
3 241 242 787 788 O
weeks 243 248 789 794 O
beyond 249 255 795 801 O
the 256 259 802 805 O
last 260 264 806 810 O
session 265 272 811 818 O
of 273 275 819 821 O
radiation 276 285 822 831 B-treatment
therapy 286 293 832 839 I-treatment
; 293 294 839 840 O
local 295 300 841 846 B-treatment
palliative 301 311 847 857 I-treatment
radiation 312 321 858 867 I-treatment
therapy 322 329 868 875 I-treatment
that 330 334 876 880 O
is 335 337 881 883 O
not 338 341 884 887 O
delivered 342 351 888 897 O
to 352 354 898 900 O
all 355 358 901 904 O
target 359 365 905 911 O
lesions 366 373 912 919 O
is 374 376 920 922 O
allowed 377 384 923 930 O
immediately 385 396 931 942 O
before 397 403 943 949 O
or 404 406 950 952 O
during 407 413 953 959 O
treatment 414 423 960 969 B-treatment

Patients 0 8 970 978 O
with 9 13 979 983 O
advanced 14 22 984 992 O
or 23 25 993 995 O
metastatic 26 36 996 1006 B-cancer
cancer 37 43 1007 1013 I-cancer
that 44 48 1014 1018 O
is 49 51 1019 1021 O
refractory 52 62 1022 1032 O
to 63 65 1033 1035 O
standard 66 74 1036 1044 B-treatment
therapy 75 82 1045 1052 I-treatment
, 82 83 1052 1053 O
relapsed 84 92 1054 1062 O
after 93 98 1063 1068 O
standard 99 107 1069 1077 O
therapy 108 115 1078 1085 O
, 115 116 1085 1086 O
or 117 119 1087 1089 O
who 120 123 1090 1093 O
have 124 128 1094 1098 O
no 129 131 1099 1101 O
standard 132 140 1102 1110 O
therapy 141 148 1111 1118 O
available 149 158 1119 1128 O
that 159 163 1129 1133 O
improves 164 172 1134 1142 O
survival 173 181 1143 1151 O
by 182 184 1152 1154 O
at 185 187 1155 1157 O
least 188 193 1158 1163 O
three 194 199 1164 1169 B-lower_bound
months 200 206 1170 1176 I-lower_bound

Platelets 0 9 1177 1186 B-clinical_variable
more 10 14 1187 1191 O
or 15 17 1192 1194 O
equal 18 23 1195 1200 O
to 24 26 1201 1203 O
50,000 27 33 1204 1210 B-lower_bound
/ 33 34 1210 1211 I-lower_bound
mL 34 36 1211 1213 I-lower_bound

Pregnant 0 8 1214 1222 B-pregnancy

Presence 0 8 1223 1231 O
of 9 11 1232 1234 O
cardiac 12 19 1235 1242 B-chronic_disease
disease 20 27 1243 1250 I-chronic_disease
that 28 32 1251 1255 O
, 32 33 1255 1256 O
in 34 36 1257 1259 O
the 37 40 1260 1263 O
opinion 41 48 1264 1271 O
of 49 51 1272 1274 O
the 52 55 1275 1278 O
investigator 56 68 1279 1291 O
, 68 69 1291 1292 O
increases 70 79 1293 1302 O
the 80 83 1303 1306 O
risk 84 88 1307 1311 O
of 89 91 1312 1314 O
ventricular 92 103 1315 1326 B-chronic_disease
arrhythmia 104 114 1327 1337 I-chronic_disease

Total 0 5 1338 1343 B-clinical_variable
bilirubin 6 15 1344 1353 I-clinical_variable
less 16 20 1354 1358 O
than 21 25 1359 1363 O
or 26 28 1364 1366 O
equal 29 34 1367 1372 O
to 35 37 1373 1375 O
3.0 38 41 1376 1379 B-upper_bound

Uncontrolled 0 12 1380 1392 O
intercurrent 13 25 1393 1405 B-chronic_disease
illness 26 33 1406 1413 I-chronic_disease
including 34 43 1414 1423 O
, 43 44 1423 1424 O
but 45 48 1425 1428 O
not 49 52 1429 1432 O
limited 53 60 1433 1440 O
to 61 63 1441 1443 O
, 63 64 1443 1444 O
uncontrolled 65 77 1445 1457 B-chronic_disease
infection 78 87 1458 1467 I-chronic_disease
, 87 88 1467 1468 O
uncontrolled 89 101 1469 1481 B-chronic_disease
asthma 102 108 1482 1488 I-chronic_disease
, 108 109 1488 1489 O
need 110 114 1490 1494 O
for 115 118 1495 1498 O
hemodialysis 119 131 1499 1511 B-treatment
, 131 132 1511 1512 O
need 133 137 1513 1517 O
for 138 141 1518 1521 O
ventilatory 142 153 1522 1533 B-treatment
support 154 161 1534 1541 I-treatment

